• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈涂片样本中高危型人乳头瘤病毒基因型的分布及意义不明确的非典型鳞状细胞(ASC-US)、低度鳞状上皮内病变(LSIL)和高度鳞状上皮内病变(HSIL)结果的评估

Distribution of High-risk Human Papillomavirus Genotypes in Cervical Smear Samples and Evaluation of ASC-US, LSIL, and HSIL Results.

作者信息

Tanik Eylul Beren, Bakir Ayfer, Turkmenoglu Tugba Taskin, Erdem Gul

机构信息

Department of Medical Microbiology, Ministry of Health Ankara Etlik City Hospital, Yenimahalle, Ankara, Turkey.

Department of Pathology, Ministry of Health Ankara Etlik City Hospital, Yenimahalle, Ankara, Turkey.

出版信息

J Cytol. 2024 Jan-Mar;42(1):37-42. doi: 10.4103/joc.joc_70_24. Epub 2025 Feb 11.

DOI:10.4103/joc.joc_70_24
PMID:40078342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11896115/
Abstract

CONTEXT

High-risk human papillomavirus (hrHPV) is the most common viral pathogen responsible for cervical cancers. Determining the rates of HPV positivity, genotypic distribution, and obtaining regional epidemiological data can provide guidance for preventive strategies.

AIMS

This study aims to assess HPV positivity rates, age distribution, genotyping in abnormal cytologies, and then obtain regional epidemiological data.

SETTINGS AND DESIGN

Descriptive study.

MATERIALS AND METHODS

This study included 3510 women aged ≥18, whose cervical smear samples were examined at the Microbiology Laboratory. HPV detection and genotyping in cervical smear samples were performed using the polymerase chain reaction (PCR) method. Pap smears were evaluated according to the Bethesda system.

STATISTICAL ANALYSIS USED

SPSS 23 (IBM Corp.) software was utilized for the statistical analysis of the data.

RESULTS

The positivity rate for hrHPV infection was 10%. The most common genotype was other hrHPV. The rate of multiple hrHPV positive infections was 13.6%. The highest hrHPV positivity was observed in the age group ranging from 18 to 24 age group (28.7%). HPV infections were higher in abnormal cytologies ( < 0.001), with the highest positivity in LSIL ( < 0.001). The risk of having LSIL and HSIL cytology in HPV-positive individuals was 32.59 times higher than that in HPV-negative individuals (OR = 32.59; 95% CI 16.42-64.66).

CONCLUSIONS

The hrHPV positivity was 10%, with other hrHPV strain infections being the most detected, followed by HPV 16. Due to the high detection of other hrHPV strain positivity in patients with abnormal cytology, conducting regional studies determining each hrHPV type separately, monitoring the natural course of infection with types other than HPV 16 and HPV 18, and benefiting vaccine studies are considered essential.

摘要

背景

高危型人乳头瘤病毒(hrHPV)是导致宫颈癌的最常见病毒病原体。确定HPV阳性率、基因型分布并获取区域流行病学数据可为预防策略提供指导。

目的

本研究旨在评估HPV阳性率、年龄分布、异常细胞学中的基因分型,进而获取区域流行病学数据。

设置与设计

描述性研究。

材料与方法

本研究纳入3510名年龄≥18岁的女性,其宫颈涂片样本在微生物实验室进行检测。宫颈涂片样本中的HPV检测和基因分型采用聚合酶链反应(PCR)方法。根据贝塞斯达系统对巴氏涂片进行评估。

所用统计分析方法

使用SPSS 23(IBM公司)软件对数据进行统计分析。

结果

hrHPV感染阳性率为10%。最常见的基因型是其他hrHPV。多重hrHPV阳性感染率为13.6%。在18至24岁年龄组中观察到最高的hrHPV阳性率(28.7%)。HPV感染在异常细胞学中更高(<0.001),在低度鳞状上皮内病变(LSIL)中阳性率最高(<0.001)。HPV阳性个体出现LSIL和高度鳞状上皮内病变(HSIL)细胞学的风险比HPV阴性个体高32.59倍(比值比=32.59;95%置信区间16.42 - 64.66)。

结论

hrHPV阳性率为10%,检测到的其他hrHPV毒株感染最多,其次是HPV 16。由于在异常细胞学患者中其他hrHPV毒株阳性检测率较高,开展分别确定每种hrHPV类型的区域研究、监测HPV 16和HPV 18以外类型的感染自然病程以及使疫苗研究受益被认为至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/123f/11896115/615d5496af4b/JCytol-42-37-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/123f/11896115/bb632d99f41f/JCytol-42-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/123f/11896115/f7dcc4e3689a/JCytol-42-37-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/123f/11896115/615d5496af4b/JCytol-42-37-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/123f/11896115/bb632d99f41f/JCytol-42-37-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/123f/11896115/f7dcc4e3689a/JCytol-42-37-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/123f/11896115/615d5496af4b/JCytol-42-37-g003.jpg

相似文献

1
Distribution of High-risk Human Papillomavirus Genotypes in Cervical Smear Samples and Evaluation of ASC-US, LSIL, and HSIL Results.宫颈涂片样本中高危型人乳头瘤病毒基因型的分布及意义不明确的非典型鳞状细胞(ASC-US)、低度鳞状上皮内病变(LSIL)和高度鳞状上皮内病变(HSIL)结果的评估
J Cytol. 2024 Jan-Mar;42(1):37-42. doi: 10.4103/joc.joc_70_24. Epub 2025 Feb 11.
2
The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.通过聚合酶链反应(PCR)检测正常和异常宫颈阴道细胞学的女性中人乳头瘤病毒(HPV)基因型的流行情况。
Ginekol Pol. 2018;89(2):62-67. doi: 10.5603/GP.a2018.0011.
3
Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.根据2001年贝塞斯达术语分类的薄层液基巴氏试验中人乳头瘤病毒类型的分布及其与患者年龄和活检结果的相关性。
Cancer. 2006 Mar 1;106(5):1054-64. doi: 10.1002/cncr.21664.
4
Detection of high-risk human papillomavirus RNA in urine for cervical cancer screening with HPV 16 & 18/45 genotyping.采用HPV 16及18/45基因分型检测尿液中的高危型人乳头瘤病毒RNA用于宫颈癌筛查。
Heliyon. 2020 Apr 22;6(4):e03745. doi: 10.1016/j.heliyon.2020.e03745. eCollection 2020 Apr.
5
[Triage value of high risk human papilloma virus detection in women with abnormal cervical cytology].[高危型人乳头瘤病毒检测在宫颈细胞学异常女性中的分流价值]
Zhonghua Yi Xue Za Zhi. 2008 Apr 29;88(17):1173-6.
6
P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women.P16/Ki-67 双染色在人乳头瘤病毒 DNA 阳性检测中的应用对预测东北泰国女性宫颈病变的意义。
Asian Pac J Cancer Prev. 2022 Oct 1;23(10):3405-3411. doi: 10.31557/APJCP.2022.23.10.3405.
7
Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.分子巴氏涂片:人乳头瘤病毒基因型以及腺苷酸环化酶8、钙黏蛋白8和锌指蛋白582的DNA甲基化作为高级别宫颈细胞学的综合生物标志物
Clin Epigenetics. 2016 Sep 13;8(1):96. doi: 10.1186/s13148-016-0263-9. eCollection 2016.
8
Genotype distribution of cervical HPV among Caribbean women in a population-based study in Martinique: The DEPIPAPUFR study.基于人群的法属马丁尼克岛加勒比妇女 HPV 基因型分布:DEPIPAPUFR 研究。
PLoS One. 2021 Oct 7;16(10):e0257915. doi: 10.1371/journal.pone.0257915. eCollection 2021.
9
High-risk Human Papillomavirus (hrHPV) Prevalence and Genotype Distribution among Turkish Women.土耳其女性中高危型人乳头瘤病毒(hrHPV)的流行率及基因型分布
J Cytol. 2023 Jan-Mar;40(1):42-48. doi: 10.4103/joc.joc_129_22. Epub 2023 Mar 20.
10
Safety of screening with Human papillomavirus testing for cervical cancer at three-year intervals in a high-risk population: experience from the LAMS study.高危人群中每三年进行一次人乳头瘤病毒检测用于宫颈癌筛查的安全性:来自LAMS研究的经验
J Med Screen. 2008;15(2):97-104. doi: 10.1258/jms.2008.007061.

引用本文的文献

1
Screening for Cervical Cancer and Early Treatment (SCCET) Project-The Programmatic Data of Romanian Experience in Primary Screening for High-Risk HPV DNA.宫颈癌筛查与早期治疗(SCCET)项目——罗马尼亚高危型人乳头瘤病毒DNA初筛经验的项目数据
Diagnostics (Basel). 2025 Aug 18;15(16):2066. doi: 10.3390/diagnostics15162066.

本文引用的文献

1
HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK.人乳头瘤病毒与宫颈癌:英国流行病学及筛查情况综述
Pathogens. 2023 Feb 11;12(2):298. doi: 10.3390/pathogens12020298.
2
Molecular Detection Methods in HPV-Related Cancers.人乳头瘤病毒相关癌症的分子检测方法
Front Oncol. 2022 Apr 27;12:864820. doi: 10.3389/fonc.2022.864820. eCollection 2022.
3
Cancer cervix: Epidemiology and disease burden.子宫颈癌:流行病学与疾病负担。
Cytojournal. 2022 Mar 29;19:21. doi: 10.25259/CMAS_03_02_2021. eCollection 2022.
4
Prevalence of Human Papillomavirus Among Women Older than Recommended Age for Vaccination by Birth Cohort, United States 2003‒2016.美国 2003-2016 年按出生队列统计推荐疫苗接种年龄以上女性的人乳头瘤病毒流行率。
J Infect Dis. 2022 Jan 5;225(1):94-104. doi: 10.1093/infdis/jiab334.
5
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation.人乳头瘤病毒及相关疾病的流行病学和负担、分子发病机制和疫苗评估。
Front Public Health. 2021 Jan 20;8:552028. doi: 10.3389/fpubh.2020.552028. eCollection 2020.
6
How to triage HPV positive cases: Results of four million females.如何对 HPV 阳性病例进行分诊:四百万女性的结果。
Gynecol Oncol. 2020 Jul;158(1):105-111. doi: 10.1016/j.ygyno.2020.04.698. Epub 2020 Apr 30.
7
The early detection of cervical cancer. The current and changing landscape of cervical disease detection.宫颈癌的早期检测。宫颈疾病检测的现状和变化情况。
Cytopathology. 2020 Jul;31(4):258-270. doi: 10.1111/cyt.12835.
8
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis.2018 年宫颈癌发病率和死亡率的估计:全球分析。
Lancet Glob Health. 2020 Feb;8(2):e191-e203. doi: 10.1016/S2214-109X(19)30482-6. Epub 2019 Dec 4.
9
HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey.土耳其宫颈细胞学正常和异常女性中的人乳头瘤病毒基因型分布情况
Rev Esp Quimioter. 2019 Dec;32(6):516-524. Epub 2019 Oct 23.
10
Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: A systematic review and meta-analysis.人乳头瘤病毒 16 型和 18 型与伊朗女性宫颈癌的相关性及其诊断方法的系统评价和荟萃分析。
Curr Probl Cancer. 2020 Feb;44(1):100493. doi: 10.1016/j.currproblcancer.2019.06.008. Epub 2019 Jul 2.